SHSE:688765 (China)
Â
Ordinary Shares - Class A
Â¥
55.79
+3.61 (+6.92%)
Jul 16
Business Description
Wuhan Healthgen Biotechnology Corp
ISIN : CNE100007D17
Share Class Description:
SHSE:688765: Ordinary Shares - Class ATotal Employee Number:
253Compare
Compare
Traded in other countries / regions
688765.China IPO Date
2025-10-28Description
Wuhan Healthgen Biotechnology Corp is engaged in Research, development, production and commercialization of plant-based molecular medicines.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 1.29 | |||||
Equity-to-Asset | 0.79 | |||||
Debt-to-Equity | 0.11 | |||||
Debt-to-EBITDA | -2.24 | |||||
Piotroski F-Score | N/A/9 | |||||
Altman Z-Score | 14.02 | |||||
WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 49.1 | |||||
3-Year EBITDA Growth Rate | 15.9 | |||||
3-Year EPS without NRI Growth Rate | -4.3 | |||||
3-Year FCF Growth Rate | -13.1 | |||||
3-Year Book Growth Rate | 34.4 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 64.32 | |||||
9-Day RSI | 58.84 | |||||
14-Day RSI | 55.32 | |||||
3-1 Month Momentum % | -29.62 | |||||
6-1 Month Momentum % | -42.75 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 3.32 | |||||
Quick Ratio | 3.06 | |||||
Cash Ratio | 0.7 | |||||
Days Inventory | 1237.91 | |||||
Days Sales Outstanding | 13.33 | |||||
Days Payable | 3523.07 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -10.1 | |||||
Shareholder Yield % | -1.5 |
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 37.44 | |||||
Operating Margin % | -281.02 | |||||
Net Margin % | -271.6 | |||||
EBITDA Margin % | -259.5 | |||||
FCF Margin % | -1565.94 | |||||
OCF Margin % | -331.83 | |||||
ROE % | -9.85 | |||||
ROA % | -6.39 | |||||
ROIC % | -8.28 | |||||
3-Year ROIIC % | -0.01 | |||||
ROC (Joel Greenblatt) % | -8.08 | |||||
ROCE % | -7.16 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 326.28 | |||||
PB Ratio | 6.96 | |||||
Price-to-Tangible-Book | 7.16 | |||||
EV-to-EBIT | -138.63 | |||||
EV-to-EBITDA | -138.63 | |||||
EV-to-Revenue | 359.76 | |||||
EV-to-FCF | -22.97 | |||||
| Price-to-Net-Current-Asset-Value | 18.06 | |||||
Earnings Yield (Greenblatt) % | -0.72 | |||||
FCF Yield % | -4.19 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Wuhan Healthgen Biotechnology Corp Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 53.346 | ||
| EPS (TTM) (Â¥) | -0.476 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 55.32 | ||
| 14-Day ATR (Â¥) | 2.879842 | ||
| 20-Day SMA (Â¥) | 49.154 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range (Â¥) | 42.08 - 132.03 | ||
| Shares Outstanding (Mil) | 357.5 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Wuhan Healthgen Biotechnology Corp Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Wuhan Healthgen Biotechnology Corp Stock Events
| Event | Date | Price (Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Wuhan Healthgen Biotechnology Corp Frequently Asked Questions
What is Wuhan Healthgen Biotechnology Corp(SHSE:688765)'s stock price today?
The current price of SHSE:688765 is ¥55.79. The 52 week high of SHSE:688765 is ¥132.03 and 52 week low is ¥42.08.
When is next earnings date of Wuhan Healthgen Biotechnology Corp(SHSE:688765)?
The next earnings date of Wuhan Healthgen Biotechnology Corp(SHSE:688765) is .
Does Wuhan Healthgen Biotechnology Corp(SHSE:688765) pay dividends? If so, how much?
Wuhan Healthgen Biotechnology Corp(SHSE:688765) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Wuhan Healthgen Biotechnology Corp
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers